271 related articles for article (PubMed ID: 7854521)
1. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression.
Hohol MJ; Orav EJ; Weiner HL
Neurology; 1995 Feb; 45(2):251-5. PubMed ID: 7854521
[TBL] [Abstract][Full Text] [Related]
2. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.
Hohol MJ; Orav EJ; Weiner HL
Mult Scler; 1999 Oct; 5(5):349-54. PubMed ID: 10516779
[TBL] [Abstract][Full Text] [Related]
3. MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment.
Cohen YC; Hassin-Baer S; Olmer L; Barishev R; Goldhammer Y; Freedman L; Mozes B
Mult Scler; 2000 Oct; 6(5):355-61. PubMed ID: 11064447
[TBL] [Abstract][Full Text] [Related]
4. Gait variability across the disability spectrum in people with multiple sclerosis.
Kalron A
J Neurol Sci; 2016 Feb; 361():1-6. PubMed ID: 26810506
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.
Bin Sawad A; Seoane-Vazquez E; Rodriguez-Monguio R; Turkistani F
Curr Med Res Opin; 2016 Dec; 32(12):1969-1974. PubMed ID: 27603119
[TBL] [Abstract][Full Text] [Related]
6. Refining an automatic EDSS scoring expert system for routine clinical use in multiple sclerosis.
Gaspari M; Saletti D; Scandellari C; Stecchi S
IEEE Trans Inf Technol Biomed; 2009 Jul; 13(4):501-11. PubMed ID: 19273014
[TBL] [Abstract][Full Text] [Related]
7. Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
Kahraman T; Savci S; Coskuner Poyraz E; Ozakbas S; Idiman E
NeuroRehabilitation; 2016; 38(1):7-14. PubMed ID: 26889793
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure.
Pau M; Caggiari S; Mura A; Corona F; Leban B; Coghe G; Lorefice L; Marrosu MG; Cocco E
Mult Scler Relat Disord; 2016 Nov; 10():187-191. PubMed ID: 27919488
[TBL] [Abstract][Full Text] [Related]
9. Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis.
Solà-Valls N; Vicente-Pascual M; Blanco Y; Solana E; Llufriu S; Martínez-Heras E; Martínez-Lapiscina EH; Sepúlveda M; Pulido-Valdeolivas I; Zubizarreta I; Saiz A
Mult Scler Relat Disord; 2019 Jan; 27():333-339. PubMed ID: 30472411
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
Rabadi MH; Vincent AS
Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
[TBL] [Abstract][Full Text] [Related]
11. The psychometric properties of clinical rating scales used in multiple sclerosis.
Sharrack B; Hughes RA; Soudain S; Dunn G
Brain; 1999 Jan; 122 ( Pt 1)():141-59. PubMed ID: 10050902
[TBL] [Abstract][Full Text] [Related]
12. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.
Noseworthy JH; Vandervoort MK; Wong CJ; Ebers GC
Neurology; 1990 Jun; 40(6):971-5. PubMed ID: 2189084
[TBL] [Abstract][Full Text] [Related]
13. Disability progression in multiple sclerosis is slower than previously reported.
Tremlett H; Paty D; Devonshire V
Neurology; 2006 Jan; 66(2):172-7. PubMed ID: 16434648
[TBL] [Abstract][Full Text] [Related]
14. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis.
Langeskov-Christensen D; Feys P; Baert I; Riemenschneider M; Stenager E; Dalgas U
J Neurol Sci; 2017 Nov; 382():131-136. PubMed ID: 29111007
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
Sayao AL; Devonshire V; Tremlett H
Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
[TBL] [Abstract][Full Text] [Related]
16. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
D'hooghe MB; Haentjens P; Nagels G; De Keyser J
Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
[TBL] [Abstract][Full Text] [Related]
17. Disability profile of MS did not change over 10 years in a population-based prevalence cohort.
Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Rodriguez M
Neurology; 2004 Feb; 62(4):601-6. PubMed ID: 14981177
[TBL] [Abstract][Full Text] [Related]
18. Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group.
Goodkin DE; Cookfair D; Wende K; Bourdette D; Pullicino P; Scherokman B; Whitham R
Neurology; 1992 Apr; 42(4):859-63. PubMed ID: 1565242
[TBL] [Abstract][Full Text] [Related]
19. Composite end points to assess delay of disability progression by MS treatments.
Zhang J; Waubant E; Cutter G; Wolinsky J; Leppert D
Mult Scler; 2014 Oct; 20(11):1494-501. PubMed ID: 24675040
[TBL] [Abstract][Full Text] [Related]
20. The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions.
Edwards T; Pilutti LA
Mult Scler Relat Disord; 2017 Aug; 16():31-39. PubMed ID: 28755682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
